Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001161697-11-000722
Filing Date
2011-08-12
Accepted
2011-08-12 17:11:12
Documents
12
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR 06-30-2011 form_10-q.htm 10-Q 706098
2 RULE 13A-14(A)/ 15D-14(A) CERTIFICATION OF CEO ex_31-1.htm EX-31 5741
3 RULE 13A-14(A)/ 15D-14(A) CERTIFICATION OF CFO ex_31-2.htm EX-31 5714
4 SECTION 1350 CERTIFICATION OF CEO ex_32-1.htm EX-32 2775
5 SECTION 1350 CERTIFICATION OF CFO ex_32-2.htm EX-32 2771
6 GRAPHIC chart.jpg GRAPHIC 19191
  Complete submission text file 0001161697-11-000722.txt   3564239

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE ltus-20110630.xml EX-101.INS 589343
8 XBRL SCHEMA FILE ltus-20110630.xsd EX-101.SCH 18345
9 XBRL CALCULATION FILE ltus-20110630_cal.xml EX-101.CAL 38250
10 XBRL DEFINITION FILE ltus-20110630_def.xml EX-101.DEF 58727
11 XBRL LABEL FILE ltus-20110630_lab.xml EX-101.LAB 211899
12 XBRL PRESENTATION FILE ltus-20110630_pre.xml EX-101.PRE 92340
Mailing Address 16 CHENG ZHUANG ROAD FENG TAI DISTRICT BEIJING F4 100071
Business Address 16 CHENG ZHUANG ROAD FENG TAI DISTRICT BEIJING F4 100071 86-10-63899868
Lotus Pharmaceuticals, Inc. (Filer) CIK: 0001292087 (see all company filings)

EIN.: 200507918 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32581 | Film No.: 111032213
SIC: 2834 Pharmaceutical Preparations